Vivozon Healthcare Inc (082800) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.055x

Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.055x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.41 Billion ≈ $-3.67 Million USD) by net assets (₩97.74 Billion ≈ $66.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 082800 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Vivozon Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fountaine Pajo PA:ALFPC	-0.038x
Jinzhou Port Co Ltd A SHG:600190	-22.872x
BBMG Corporation F:9BM	0.032x
STLLR Gold Inc. TO:STLR	-0.045x
NOVAREX Co.Ltd KQ:194700	0.041x
Paragon Care Ltd AU:PGC	-0.088x
Stellar V Capital Corp. Class A Ordinary Shares NASDAQ:SVCC	-0.001x
Athens Medical C.S.A. AT:IATR	0.029x

Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Vivozon Healthcare Inc (082800) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.66 Billion ≈ $49.24 Million	₩-6.87 Billion ≈ $-4.65 Million	-0.095x	-275.53%
2024-12-31	₩106.43 Billion ≈ $72.12 Million	₩5.73 Billion ≈ $3.88 Million	0.054x	+87.33%
2023-12-31	₩104.07 Billion ≈ $70.52 Million	₩2.99 Billion ≈ $2.03 Million	0.029x	+191.55%
2022-12-31	₩105.84 Billion ≈ $71.72 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.031x	+84.72%
2021-12-31	₩85.12 Billion ≈ $57.68 Million	₩-17.50 Billion ≈ $-11.86 Million	-0.206x	-579.12%
2020-12-31	₩107.80 Billion ≈ $73.06 Million	₩4.62 Billion ≈ $3.13 Million	0.043x	+220.09%
2019-12-31	₩109.00 Billion ≈ $73.87 Million	₩-3.89 Billion ≈ $-2.64 Million	-0.036x	+46.71%
2018-12-31	₩68.45 Billion ≈ $46.38 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.067x	+76.48%
2017-12-31	₩16.10 Billion ≈ $10.91 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.285x	-210.44%
2016-12-31	₩22.74 Billion ≈ $15.41 Million	₩5.87 Billion ≈ $3.98 Million	0.258x	+128.52%
2015-12-31	₩24.65 Billion ≈ $16.71 Million	₩2.78 Billion ≈ $1.89 Million	0.113x	+26.48%
2014-12-31	₩33.90 Billion ≈ $22.97 Million	₩3.03 Billion ≈ $2.05 Million	0.089x	--

About Vivozon Healthcare Inc

KQ:082800 Korea Pharmaceuticals

Market Cap

$164.00 Million

₩242.00 Billion KRW

Market Cap Rank

#17399 Global

#709 in Korea

Share Price

₩3250.00

Change (1 day)

-10.10%

52-Week Range

₩2180.00 - ₩8200.00

All Time High

₩16500.00